Integrins as a drug target in liver fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Integrins as a drug target in liver fibrosis

Published:2022-01-28 Issue:3 Volume:42 Page:507-521
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Rahman Syedia R.¹²³^ORCID,Roper James A.⁴,Grove Jane I.¹³,Aithal Guruprasad P.¹³,Pun K. Tao⁴,Bennett Andrew J.¹²³

Affiliation:

1. NIHR Nottingham Biomedical Research Centre Nottingham University Hospitals NHS Trust and University of Nottingham Nottingham UK

2. FRAME Alternatives Laboratory Life Sciences University of Nottingham Medical School Queen's Medical Centre Nottingham UK

3. Nottingham Digestive Diseases Centre, Translational Medical Sciences, Medicine University of Nottingham Nottingham UK

4. Novel Human Genetics Research Unit GlaxoSmithKline Stevenage UK

Funder

GlaxoSmithKline

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15157

Reference136 articles.

1. Liver fibrosis

2. Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening

3. Molecular pathogenesis of liver fibrosis;Brenner DA;Trans Am Clin Climatol Assoc,2009

4. High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study

5. Cellular and molecular mechanisms of fibrosis

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Landscape of extrachromosomal circular DNAs, transcriptome, and proteome analysis reveals insights into alcoholic liver cirrhosis;Gene;2024-11

2. Integrins and NAFLD-associated liver diseases: clinical associations, pathophysiological mechanisms and pharmacological implications;Acta Biochimica et Biophysica Sinica;2024-09-01

3. Potential of αvβ6 and αvβ1 integrin inhibition for treatment of idiopathic pulmonary fibrosis;Expert Opinion on Therapeutic Targets;2024-07-02

4. The current landscape of antifibrotic therapy across different organs: A systematic approach;Pharmacological Research;2024-07

5. Stem cell-based therapy for fibrotic diseases: mechanisms and pathways;Stem Cell Research & Therapy;2024-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3